Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

BioCardia (BCDA) Q2 2026 Earnings Call Transcript

The company said positive PMDA consultations and FDA feedback support approval plans as Japan remains a key market with 300,000 ischemic heart failure patients.

Summary by The Motley Fool
Japan regulatory progress and narrowed losses drive CardiAMP advancement.

1 Articles

The Motley FoolThe Motley Fool
Lean Left

BioCardia (BCDA) Q2 2026 Earnings Call Transcript

Japan regulatory progress and narrowed losses drive CardiAMP advancement.

·Alexandria, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Wednesday, August 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Artificial Intelligence icon

Artificial Intelligence

Infrastructure icon

Infrastructure

Cisco icon

Cisco

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal